REMEDISC
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Apr 2023)
What this means for you
This application is over — abandoned 03 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88436119
- Mark type
- Stylized text
- Filed
- 17 May 2019
- Published for opposition
- 07 Jan 2020
- Abandoned
- 03 Apr 2023
- Attorney of record
- Tram Anh Nguyen
Goods and services
- Class 001 — Chemicals: Biomedical compounds, namely, amino acids for medical purposes administered for medical therapies; amino acids for medical purposes administered by injection for treatment of spinal diseases or disorders; 7-amino acid peptide chain, namely, amino acids for medical purposes administered by intradiscal injection for the treatment of lumbar degenerative disc disease
Owner
- Spine Biopharma, LLC, New York, NY, US
- Spine Biopharma, LLC, New York, NY, US
Prosecution history
- 03 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Mar 2023 — ASSIGNED TO EXAMINER
- 17 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2022 — SOU EXTENSION 5 GRANTED
- 06 Sept 2022 — SOU EXTENSION 5 FILED
- 16 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2022 — SOU EXTENSION 4 GRANTED
- 03 Mar 2022 — SOU EXTENSION 4 FILED
- 03 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2021 — SOU EXTENSION 3 GRANTED
- 24 Aug 2021 — SOU EXTENSION 3 FILED